4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-057368
Director sold 16,000 shares at $14.69 ($235,040)
- Director acquired 16,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ball Jack Director | 2022-11-14 | Option exercise | +16,000 | $0.40 | $6,400 | 19,000 | D |
| Ball Jack Director | 2022-11-14 | Sale | −16,000 | $14.69 | $235,040 | 3,000 | D |
| Derivatives | |||||||
| Ball Jack Director | 2022-11-14 | Option exercise · Stock Option (Right to Buy) | −16,000 | 10,666 | D | ||
| Open-market sales · 16,000 sh · avg $14.69 · $235,040 | |||||||
Loading xslF345X03/doc4.xml…